Delve into Sanofi's "play to win" strategy as investments are ramping up after their consumer health division's divestment.

The consumer health unit of Sanofi boasts a portfolio inclusive of popular over-the-counter products like Phytoxil cough syrups, Icy Hot pain relief gels, and Dulcolax laxative tablets.

In its third-quarter results update, Sanofi said the consumer health unit – which owns brands ... The range of consumer healthcare products it offers will also be “streamlined” ahead of ...

Sanofi (NASDAQ:SNY) is close to a deal to sell its consumer health unit to private equity ... unit's potential liability from ...

Sanofi’s divestment continues a trend among pharma companies to divest their consumer health divisions to focus on prescription drugs, recognising that consumer health products require different ...

On October 21, 2024, Sanofi (NASDAQ: SNY US (ADR), $53.83 ... are available in more than 180 countries worldwide. Consumer Health Company (Opella) (Sold-Out entity) Headquartered in France ...

Sanofi is now in “exclusive negotiations” with U.S. private equity firm Clayton, Dubilier & Rice (CD&R) to sell a 50% controlling stake in its consumer health business Opella. With the French ...

Sanofi has entered exclusive talks with US private equity company Clayton Dubilier & Rice (CD&R) over the sale of the former’s consumer health business ... most paracetamol products are referred ...

French drugmaker Sanofi's confirmation that it will sell a controlling stake in its consumer health unit to a US ... volume for Opella's sensitive products in France," Armand added, including ...

Sanofi has been trying to divest of this unit for about a year, in an attempt to focus more on its core products, which include treatments for rare diseases, cancer and other health issues ... focused ...

PARIS, Oct 17 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab said on Thursday it was "surprised" by a renewed, higher offer for its consumer ... cannot give up health," he said.